Inhalers containing chlorofluorocarbons will soon be phased out

Links shared publicly online about this topic.

  • 1,238
    total visits

Inhalers containing chlorofluorocarbons will soon be phased out

pediatricsupersite.com

The FDA has announced that certain metered-dose inhalers designed to treat asthma and chronic obstructive pulmonary disease are to be removed

View full resource at pediatricsupersite.com

Tags: Asthma, COPD, Disease and Condition, FDA, Pulmonology

  • Share

Most Recently Shared on April 15, 2010 at 8:00 pm By:

Teva Respiratory Provides Resources for Patients Impacted by PRIMATENE® MIST Phase-Out | Business Wire

businesswire.com — “According to the United States (U.S.) Food and Drug Administration (FDA), the only over-the-counter (OTC) asthma inhaler containing chlorofluorocarbonView full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on October 3, 2011 at 5:58 pm By:

wheezemd Michael Blaiss, MD Physician, Doctor, and Allergist

Teva Respiratory Provides Resources for Patients Impacted by PRIMATENE® MIST Phase-Out - http://t.co/aNkABPQA

6 months ago...

Epinephrine CFC Metered-dose Inhalers - Questions and Answers

fda.gov — “Epinephrine CFC Metered-dose Inhalers - Questions and AnswersView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on September 22, 2011 at 12:58 pm By:

LungAssociation American Lung Assoc. Health Organization

Dec. 31 = Primatene Mist no longer available. Ask your doctor for #asthma medication alternatives. http://t.co/zLWIxp1W

7 months ago...

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

dld.bz — “The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. AlternView full resource at dld.bz

  • View Related
  • Share

Most Recently Shared on April 26, 2010 at 3:01 pm By:

drchacko Northside Allergy Allergist, Physician, Doctor, and Internist

Great tie into last week's earth day: FDA to remove asthma inhalers that deplete the Ozone layer.---> http://dld.bz/bvTh. Pls RT

2 years ago...

Asthma and COPD inhalers containing chlorofluorocarbons (CFCs) to be phased out - ONA

oncologynurseadvisor.com — “The FDA announced that metered-dose inhalers (MDIs) used to treat asthma and chronic obstructive pulmonary disease (COPD) that contain chlorofluorocarbons (CFCs) will be gradually removed from the market.View full resource at oncologynurseadvisor.com

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 3:23 pm By:

ONAcom OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education

Asthma and COPD inhalers containing chlorofluorocarbons (CFCs) to be phased out http://goo.gl/fb/0t7OP

2 years ago...

Asthma and COPD inhalers containing chlorofluorocarbons (CFCs) to be phased out - MPR

empr.com — “The FDA announced that metered-dose inhalers (MDIs) used to treat asthma and chronic obstructive pulmonary disease (COPD) that contain chlorofluorocarbons (CFCs) will be gradually removed from the market.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 3:03 pm By:

eMPR MPR Medical Publisher

MPR News: Asthma and COPD inhalers containing chlorofluorocarbons (CFCs) to be phased out: The FDA announced that ... http://bit.ly/9IPJjY

2 years ago...

Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out; Alternative Treatments Available

fda.gov — “The U.S. Food and Drug Administration today announced, in accordance with longstanding U.S. obligations under the Montreal Protocol on Substances that Deplete the Ozone Layer, seven metered-dose inhalers (MDI) used to treat asthma and chronic obstructive pulmonary disease (COPD) will be gradually removed from the U.S. marketplace. These inhalers contain ozone-depleting chlorofluorocarbons (CFCs), which are propellants that move medication out of the inhaler and into the lungs of patients. AlternView full resource at fda.gov

  • View Related
  • Share

Most Recently Shared on April 13, 2010 at 8:40 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

FDA - Asthma and COPD Inhalers That Contain Ozone-depleting CFCs to be Phased Out http://ow.ly/1y46M

2 years ago...

Advertisement